Salnikov, A. V., Gladkich, J., Moldenhauer, G., Volm, M., Mattern, J., & Herr, I. (2010). CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients. International journal of cancer, 126(4), . https://doi.org/10.1002/ijc.24822
Chicago-Zitierstil (17. Ausg.)Salnikov, Alexey V., Jury Gladkich, Gerhard Moldenhauer, Manfred Volm, Jürgen Mattern, und Ingrid Herr. "CD133 Is Indicative for a Resistance Phenotype but Does Not Represent a Prognostic Marker for Survival of Non-small Cell Lung Cancer Patients." International Journal of Cancer 126, no. 4 (2010). https://doi.org/10.1002/ijc.24822.
MLA-Zitierstil (9. Ausg.)Salnikov, Alexey V., et al. "CD133 Is Indicative for a Resistance Phenotype but Does Not Represent a Prognostic Marker for Survival of Non-small Cell Lung Cancer Patients." International Journal of Cancer, vol. 126, no. 4, 2010, https://doi.org/10.1002/ijc.24822.